semaglutide weight gain after stopping Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial Weight Change With Semaglutide
Description
A systematic review of clinical trials found that semaglutide therapy significantly lowered CRP values compared to placebo (SMD -0.56
In the STEP 1 clinical trial (sponsored by Novo Nordisk), adults taking Wegovy 2.4mg for 68 weeks lost an average of about 15% of their body weight
An overdose may increase the risk of serious side effects, including seizures, rapid heart rate, very high blood pressure, or severe nausea and vomiting
So it may not match injectable tirzepatide results, even as a purpose-built oral medication
